Tall girls: The social shaping of a medical therapy

Archives of Pediatrics and Adolescent Medicine

Volumn 160, Issue 10, 2006, Pages 1035-1039

  Lee, Joyce M ^a,b   Howell, Joel D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Campus Box 0456 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

BODY HEIGHT; ESTROGEN THERAPY; FEMININITY; HORMONAL THERAPY; HUMAN; MEDICAL SOCIETY; PHYSICIAN; PRIORITY JOURNAL; REVIEW; SOCIAL ASPECT; TALL STATURE;

ADOLESCENT; BODY HEIGHT; BODY IMAGE; CHILD; CULTURE; ESTROGENS; FEMALE; FEMINISM; GROWTH HORMONE; HUMANS; INTERPERSONAL RELATIONS; MALE; SOCIOLOGY;

EID: 33749490524     PISSN: 10724710     EISSN: 10724710     Source Type: Journal    
DOI: 10.1001/archpedi.160.10.1035     Document Type: Review

References (67)

1. Corner GW. The early history of the oestrogenic hormones. J Endocrinol. 1965;31:III-XVII.
2. Oudshoorn N. On measuring sex hormones: the role of biological assays in sexualizing chemical substances. Bull Hist Med. 1990;64:243-261.
3. Borell M. Organotherapy, British physiology, and discovery of the internal secretions. J Hist Biol. 1985;18:1-30.
4. Fancher TK. Some observations on anterior lobe hyperpituitarism. Endocrinology. 1932;16:611.
5. Crawford JD. Treatment of tall girls with estrogen. Pediatrics. 1978;62:1189-1195.
6. Kirklin OL, Wilder RM. Follicular hormone administration in acromegaly. Proc Staff Meet Mayo Clin. 1936;11:121-125.
7. Goldzieher MA. Treatment of excessive growth in the adolescent female. J Clin Endocrinol Metab. 1956;16:249-252.
8. Freed SC. Suppression of growth in excessively tall girls. JAMA. 1958;166:1322-1323.
9. Questions and answers. JAMA. 1959;169:305.
10. Questions and answers. JAMA. 1961;175:1036.
11. Whitelaw MJ, Foster TN. Treatment of excessive height in girls: a long-term study. J Pediatr. 1962;61:566-570.
12. Bayley N, Gordon GS, Bayer LM. Attempt to suppress excessive growth in girls by estrogen treatment: statistical evaluation. J Clin Endocrinol Metab. 1962;22:1127-1129.
13. Whitelaw MJ, Foster TN, Graham WH. Estradiol valerate: its effects on anabolism and skeletal age in the prepubertal girl. J Clin Endocrinol. 1963;23:1125-1129.
14. Greenblatt RB, McDonough PG, Mahesh VB. Estrogen therapy in inhibition of growth. J Clin Endocrinol. 1966;26:1185-1191.
15. Whitelaw MJ. Experiences in treating excessive height in girls with cyclic oestradiol valerate: a ten year survey. Acta Endocrinol (Copenh). 1967;54:473-484.
16. Frasier SD, Smith FG. Effect of estrogens on mature height in tall girls: a controlled study. J Clin Endocrinol. 1968;28:416-419.
17. Wettenhall HNB, Roche AF. Tall girls assessment and management. Aust Paediatr J. 1965;1:210-216.
18. Prader A, Zachmann M. Treatment of excessively tall girls and boys with sex hormones. Pediatrics. 1978;62(suppl):1202-1210.
19. Rosen R. The World Split Open. New York, NY: Penguin Group; 2000.
20. Hoover JE. The twin enemies of freedom: crime and communism: address before the 28th Annual Convocation of the National Council of Catholic Women. Vital Speeches Day. 1956;23:104-107.
21. Mikkelson B, Mikkelson DP. Urban legends reference pages: how to be a good wife. http://www.snopes.com/language/document/goodwife.htm. Accessed June 13, 2006.
22. Rosen R. The World Split Open. New York, NY: Penguin Group; 2000:13.
23. Beigel HG. Body height in mate selection. J Soc Psychol. 1954;39:257-268.
24. Tall girl therapy. CMAJ. 1976;114:9.
25. Bailey JD, Park E, Cowell C. Estrogen treatment of girls with constitutional tall stature. Pediatr Clin North Am. 1981;28:501-512.
26. Bierich JR. Estrogen treatment of girls with constitutional tall stature. Pediatrics. 1978;62:1196-1201.
27. Report of the Conference on Estrogen Treatment of the Young. Pediatrics. 1978;62:1087-1217.
28. Conte FA, Grumbach MM. Estrogen use in children and adolescents: a survey. Pediatrics. 1978;62:1091-1097.
29. Colle ML. The tall girl: prediction of mature height and management. Arch Dis Child. 1977;52:118-120.
30. Kuhn N, Blunck W, Stahnke N, Wiebel J, Willig RP. Estrogen treatment in tall girls. Acta Paediatr Scand. 1977;66:161-167.
31. Zachmann M, Ferrandez A, Murset G, Prader A. Estrogen treatment of excessively tall girls. Helv Paediatr Acta. 1975;30:11-30.
32. Excessive height [editorial]. BMJ. 1975;2:648-649.
33. Marshall WA. What can we do about tall girls? Arch Dis Child. 1975;50:671-673.
34. Schoen EJ, Solomon IL, Warner O, Wingerd J. Estrogen treatment of tall girls. AJDC. 1973;125:71-74.
35. Roche AF, Wettenhall HNB. The prediction of adult stature in tall girls. Aust Paediatr J. 1969;5:13-22.
36. Weimann E, Bergmann S, Bohles HJ. Oestrogen treatment of constitutional tall stature: a risk-benefit ratio. Arch Dis Child. 1998;78:148-151.
37. Binder G, Grauer ML, Wehner AV, Wehner F, Ranke MB. Outcome in tall stature: final height and psychological aspects in 220 patients with and without treatment. Eur J Pediatr. 1997;156:905-910.
38. de Waal WJ, Greyn-Fokker MH, Stijnen T, et al. Accuracy of final height prediction and effect of growth-reductive therapy in 362 constitutionally tall children. J Clin Endocrinol Metab. 1996;81:1206-1216.
39. de Waal WJ, Torn M, de Muinck Keizer-Schrama SMPF, Aarsen RSR, Drop SLS. Long term sequelae of sex steroid treatment in the management of constitutionally tall stature. Arch Dis Child. 1995;73:311-315.
40. Joss EE, Zeuner J, Zurbrugg RP, Mullis PE. Impact of different doses of ethinyl oestradiol on reduction of final height in constitutionally tall girls. Eur J Pediatr. 1994;153:797-801.
41. Normann EK, Trygstad O, Larsen S, Dahl-Jorgensen K. Height reduction in 539 tall girls treated with three different dosages of ethinyloestradiol. Arch Dis Child. 1991;66:1275-1278.
42. Gruters A, Heidemann P, Schluter H, Stubbe P, Weber B, Helge H. Effect of different oestrogen doses on final height reduction in girls with constitutional tall stature. Eur J Pediatr. 1989;149:11-13.
43. Bartsch O, Weschke B, Weber B. Oestrogen treatment of constitutionally tall girls with 0.1 mg/day ethinyl oestradiol. Eur J Pediatr. 1988;147:59-63.
44. Sorgo W, Scholler K, Heinze F, Heinze E, Teller WM. Critical analysis of height reduction in oestrogen-treated tall girls. Eur J Pediatr. 1984;142:260-265.
45. Brook CG, Stanhope R, Preece MA, Green AA, Hindmarsh PC. Oestrogen treatment of tall stature [letter]. Arch Dis Child. 1998;79:199.
46. Lecointre C, Toublanc JE. Psychological indications for treatment of tall stature in adolescent girls. J Pediatr Endocrinol Metab. 1997;10:529-531.
47. Stickler GB. Reduction of adult height in tall girls [letter]. Eur J Pediatr. 1980;134:91.
48. Lipsett MB. Estrogen use and cancer risk. JAMA. 1977;237:1112-1115.
49. Hoover R, Gray LA Sr, Cole P, MacMahon B. Menopausal estrogens and breast cancer. N Engl J Med. 1976;295:401-405.
50. Brozan N. The use of estrogen as a growth inhibitor in over-tall girls is being questioned. New York Times. February 11, 1976:55.
51. Haines A. Controlling height. New York Times. April 4, 1976:19.
52. Barnard ND, Scialli AR, Bobela S. The current use of estrogens for growth-suppressant therapy in adolescent girls. J Pediatr Adolesc Gynecol. 2002;15:23-26.
53. Rosen R. The World Split Open. New York, NY: Penguin Group; 2000:74-81.
54. Rosen R. The World Split Open. New York, NY: Penguin Group; 2000:19.
55. Metzl JM. Prozac on the Couch: Prescribing Gender in the Era of Wonder Drugs. Durham, NC: Duke University Press; 2003.
56. Rosen R. The World Split Open. New York, NY: Penguin Group; 2000:312-314.
57. Shakib S, Dunbar MD. The social construction of female and male high school basketball participation: reproducing the gender order through a two-tiered sporting institution. Sociol Perspect. 2002;45:353-378.
58. WNBA Enterprises LLC. 2003 WNBA player survey results: height. http://www.wnba.com/statistics/survey_height_2003.html. Accessed June 4, 2006.
59. Chu S, Geary K. Physical stature influences character perception in women. Pers Individ Dif. 2005;38:1927-1934.
60. Judge TA, Cable DM. The effect of physical height on workplace success and income: preliminary test of a theoretical model. J Appl Psychol. 2004;89:428-441.
61. Raben MS. Treatment of a pituitary dwarf with human growth hormone. J Clin Endocrinol Metab. 1958;18:901-903.
62. Allen DB, Fost N. hGH for short stature: ethical issues raised by expanded access. J Pediatr. 2004;144:648-652.
63. Cuttler L, Silvers JB. Growth hormone treatment for idiopathic short stature: implications for practice and policy. Arch Pediatr Adolesc Med. 2004;158:108-110.
64. US Food and Drug Administration. FDA talk paper: FDA approves Humatrope for short stature. http://www.fda.gov/bbs/topics/ANSWERS/2003/ANS01242.html. Accessed July 7, 2004.
65. Grimberg A, Kutikov JK, Cucchiara AJ. Sex differences in patients referred for evaluation of poor growth. J Pediatr. 2005;146:212-216.
66. Wyatt D. Lessons from the national cooperative growth study. Eur J Endocrinol. 2004;151(suppl 1):S55-S59.
67. Elliott C. Better Than Well: American Medicine Meets the American Dream. New York, NY: WW Norton Co & Inc; 2003.